About: Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) наукова стаття, опублікована у 2019 (uk) scientific article published on 29 March 2019 (en)
publication date	wds:Q64101552-CEB6904C-0366-4CF2-8CAA-E993EB83674B
publication date	2019-03-29 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64101552-6E0E6508-5FD9-45B2-954D-9EE2578935F5
language of work or name	English
cites work	wds:Q64101552-08447CE0-E31E-4611-9CA7-3E033379ABD9 wds:Q64101552-13BF2587-247E-4525-8EB4-EF4E194F5C28 wds:Q64101552-19D14919-7789-4DF2-9A84-DC66A6A45403 wds:Q64101552-1EE466E5-17D3-4B28-B07B-CB47047D424C wds:Q64101552-23A42979-7C9D-459A-8B83-0BFCA69BF47E wds:Q64101552-2768C0B6-EC47-4236-A5B9-7102298B4E31 wds:Q64101552-27CB3BB3-E3FE-436C-9EFA-148ADFA79DBB wds:Q64101552-2ACFEACE-26EE-4ADE-9CCD-21F4488D38EC wds:Q64101552-2D9D922A-B5A0-4A57-BC2F-5CA4E8426A3F wds:Q64101552-2F6E3190-8016-469D-A1BE-474A02FF428A wds:Q64101552-31336D10-75A9-4629-91AF-172EA5705762 wds:Q64101552-3B562FF5-A81E-484D-833C-8F9C0651D490 wds:Q64101552-49E36414-3D60-4993-9A4E-371F4183EB70 wds:Q64101552-5A591345-4CF5-46AF-84A4-516CC84F059E wds:Q64101552-6344936F-FED7-4296-80AF-F1FB1A237CE8 wds:Q64101552-64E06D90-84F8-4D06-8D81-0AFAA599DCF4 wds:Q64101552-710BC5C1-A148-41DB-8846-51DDA9088D0F wds:Q64101552-7E2F96C7-D955-4750-B6C8-762FB6536DCA wds:Q64101552-8EE378E7-6019-40EE-B781-14EE4979EA46 wds:Q64101552-9B51528D-A5EA-4273-821D-2AFBB4F45F3D wds:Q64101552-A1C8C293-CFE3-48AC-A438-AC2F73714D73 wds:Q64101552-A82BB981-04F8-4A57-AA89-06E44D00D213 wds:Q64101552-A9C1E10A-9C5B-496D-BC0A-38A92BF42005 wds:Q64101552-B1DFCA23-6622-43B9-913E-6E899F62780C wds:Q64101552-C6B32F3E-D6FC-4820-9A6D-C7E1D246AC97 wds:Q64101552-C6DCEE3A-810A-48F9-BA7A-89D410EA648C wds:Q64101552-C888E853-38E6-4C57-A66C-3BBF3C50E05D wds:Q64101552-CA1714DB-9F86-4729-9099-F2AAF307E7AD wds:Q64101552-D3B073F9-8CAB-4856-9792-802EA14A0373 wds:Q64101552-DF24A7D3-B624-49B2-A793-F17F74E3EC9E wds:Q64101552-E3F39447-5C64-4238-9449-7DEDB2F1C516 wds:Q64101552-E535EE39-45F7-458C-A316-D2699AC1A9B7 wds:Q64101552-ED76D9A9-D1E6-4364-998C-91FEE68B3BA0 wds:Q64101552-EE724693-F1F7-4F28-9A05-372680ECB333 wds:Q64101552-F736F747-1A94-48F7-BCBC-2B7A8320FB49 wds:Q64101552-FCFE48D9-4E5E-4691-8E3F-6F7F878B1E68 wds:Q64101552-FE7233B5-6FCE-41D5-80E6-0613F01E0DDD
cites work	Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis. Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). Standardisation of spirometry Cystic fibrosis Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm The phenotypic consequences of CFTR mutations Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover beta-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo Differentiation of Receptor Systems activated by Sympathomimetic Amines Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure Plasma renin activity and plasma prorenin assays. Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part I: Conventional techniques Effects of an inhaled β2-agonist on cardiovascular function and sympathetic activity in healthy subjects. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate Cardiac involvement in cystic fibrosis revealed by a ventricular arrhythmia Mechanism of elevated plasma noradrenaline in the course of essential hypertension Genotype-phenotype correlation for pulmonary function in cystic fibrosis. An open-circuit method for determining lung diffusing capacity during exercise: comparison to rebreathe Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands Blood flow regulation and oxidative stress during submaximal cycling exercise in patients with cystic fibrosis CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response Left ventricular and aortic dysfunction in cystic fibrosis mice Cor pulmonale in cystic fibrosis
author name string	wds:Q64101552-03E46DB0-2F9E-4EAD-8952-EA40F77AAAF3 wds:Q64101552-363FB003-EA2E-4AED-832F-2E0C9012A512 wds:Q64101552-3C55AFD9-AD0B-4035-BF61-97B9ACC8BFD6 wds:Q64101552-72254346-1549-46C8-ACDD-76325F79AD82 wds:Q64101552-A006FFCD-7D1E-4D4A-B587-EB76985A8CE9 wds:Q64101552-A3DFD296-A0E5-422D-AFCF-3593E4A2D50F
author name string	Wayne J Morgan Courtney M Wheatley Eric M Snyder Theresa A Laguna Erik H Van Iterson Alexander L Bisch
rdfs:label	Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis (en) Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis (nl)
skos:prefLabel	Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis (en) Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software